Background: Guidelines recommend the use of multiple pharmacologic agents and/or mechanical compressive devices for prevention of venous thromboembolism, but preference for any specific agent is no longer given in regard to safety or efficacy. Objective: To compare postoperative bleeding rates in patients receiving enoxaparin, rivaroxaban, or aspirin for thromboprophylaxis after undergoing elective total hip arthroplasty or total knee arthroplasty. Methods: This retrospective cohort analysis evaluated patients who received thromboprophylaxis with either enoxaparin, rivaroxaban, or aspirin. All data were collected from the electronic medical record. The primary outcome was any postoperative bleeding. Results: A total of 1244 patients were included with 366 in the aspirin, 438 in the enoxaparin, and 440 in the rivaroxaban arms. Those who received aspirin or enoxaparin were less likely to experience any bleeding compared to those patients who received rivaroxaban (P <.05). There was also a lower rate of major bleeding in these groups, but the differences were not significant. Conclusions: Aspirin and enoxaparin conferred similar bleeding risks, and both exhibited less bleeding than patients who received rivaroxaban.

Background: The Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary Embolism (RECORD) 1 to 4 trials compared rivaroxaban 10 mg daily with commonly used doses of enoxaparin and demonstrated similar rates of VTE and bleeding. Objective: To evaluate bleeding events between patients who received enoxaparin or rivaroxaban for prevention of venous thromboembolism (VTE) following total hip arthroplasty (THA) or total knee arthroplasty (TKA). Methods: Retrospective cohort that compared patients undergoing THA and TKA who received enoxaparin (enoxaparin) with those who received rivaroxaban (rivaroxaban) and also with those who received enoxaparin in the RECORD 1 to 4 trials (enoxaparin RECORD). The primary outcome was any postoperative bleeding, defined as a composite of major and clinically relevant nonmajor bleeding based on the definitions in the RECORD 1 to 4 trials. Results: There was a lower rate of any postoperative bleeding (2.2% vs 6.8%, P = 0.004) in patients who received enoxaparin compared with rivaroxaban, and bleeding rates between the enoxaparin group and the enoxaparin RECORD groups were similar (2.2% vs 2.5%, P = 0.085). Major bleeding in the enoxaparin group (0.2%) was not significantly different from that in the rivaroxaban group (1.4%, P = 0.12) or the RECORD group (0.2%, P = 0.93). Clinically relevant nonmajor bleeding was also lower in the enoxaparin group compared with the rivaroxaban group (2.0% vs 5.5%, P = 0.012). Conclusions: The use of enoxaparin for VTE prophylaxis following THA and TKA was associated with a lower rate of the primary outcome (any postoperative bleeding) compared with the use of rivaroxaban in a similar cohort of patients.

No description available.

No description available.

No description available.

No description available.

Hintergrund: Die Verletzung eines großen, venösen Gefäßes während eines lapa-roskopischen Eingriffs könnte die Entstehung einer fulminanten Gasembolie begüns-tigen. Die Verwendung von Helium als Insufflationsgas könnte aufgrund der geringen Löslichkeit ein deutlich erhöhtes Auftreten klinisch relevanter Gasembolien verursa-chen. Methodik: Bei insgesamt 20 Versuchstieren wurde unter Verwendung von CO2 [n=10] oder Helium [n=10)] als Insufflationsgase die Vena Cava inferior laparoskopisch inzi-diert. Nach 30 Sekunden wurde die Vene abgeklemmt, die Inzision laparoskopisch genäht und die Vene wieder geöffnet. Perioperativ wurden kontinuierlich Herzfre-quenz (HF), mittlerer arterieller Blutdruck (MAP), pulmonal arterieller Druck (PAP), pulmonal arterieller Verschlußdruck (PAWP), zentralvenöser Druck (ZVD), endexspi-ratorisches CO2 (ETCO2), Herzminutenvolumen (HMV), arterielle Blutgase (pH, Pa-CO2, PaO2) und arterielle Sauerstoffsättigung bestimmt. Ergebnisse: Die Letalität betrug 0% (mittlerer Blutverlust CO2, 157±50 ml; Helium, 173±83 ml). HMV und MAP zeigten in beiden Gruppen nach Inzision der Vene einen Abfall, der jedoch nach kurzer Zeit wieder vollständig kompensiert wurde. Das en-dexspiratorische CO2 stieg signifikant nach Beginn der CO2 Insufflation an (p / Background: Injury of venous vessels during elevated intraperitoneal pressure is thought to cause possible fatal gas embolism, and helium may be dangerous be-cause of its low solubility. Methods: Twenty pigs underwent laparoscopy with either CO2 (n=10) or helium (n=10) with a pressure of 15 mmHg and standardized lacera-tion (1 cm) of the vena cava inferior. After 30 s, the vena cava was clamped, closed endoscopically by a running suture and unclamped again. During the procedure changes of cardiac output (CO), heart rate (HR), mean arterial pressure (MAP), cen-tral venous pressure (CVP), pulmonary artery pressure (PAP), pulmonary artery wedge pressure (PAWP), end tidal CO2 pressure (PETCO2), and arterial blood gas analyses (pH, pO2 and pCO2) were investigated. Results: No animal died during the experimental course (mean blood loss during laceration: CO2, 157±50 ml; helium, 173±83 ml). MAP and CO values showed a decrease after laceration of the vena cava in both groups that had already been completely compensated for before sutur-ing. PETCO2 increased significantly after CO2 insufflation (P

Introdução: A hipertensão pulmonar tromboembólica crônica (HPTEC) está incluída no grupo 4 da Classificação Internacional de Hipertensão Pulmonar (HP). É caracterizada pela persistência de obstrução por trombos sanguíneos na circulação pulmonar, associada à presença de HP, após três meses de anticoagulação efetiva. O tratamento de escolha é a cirurgia de tromboendarterectomia pulmonar (TEAP), mas alguns dos mecanismos fisiopatológicos envolvidos nesta forma de hipertensão ainda permanecem incertos. O redirecionamento dos fluxos sanguíneos pulmonares e a hipóxia exercem papel importante na HPTEC, como também em casos de hipertensão pulmonar residual, após a cirurgia de TEAP. Entretanto, existem poucos dados sobre as respostas das células endoteliais pulmonares a essas mudanças de fluxo e de oxigenação, surgindo a necessidade do estudo da proteostase celular nesta doença. Objetivo: (A) Caracterização morfológica das células em culturas provenientes de artéria pulmonar de pacientes com HPTEC submetidos à TEAP. (B) Avaliação da resposta das células endoteliais, a partir da análise de proteínas envolvidas na proteostase celular, quando submetidas a diferentes níveis de stress mecânico e à hipóxia. Método: Trombos extraídos por TEAP foram processados, as células retiradas foram cultivadas, marcadas com CD31 e submetidas a stress mecânico por vinte e quatro horas, constituindo o grupo HPTEC. A proteostase celular foi avaliada pela medida de proteínas expressas por essas células, tanto em culturas quanto pela análise imuno-histoquímica do tecido vascular pulmonar. Como grupo controle foram utilizadas células endoteliais pulmonares humanas de linhagem (CE) e tecido de artérias pulmonares de doadores de transplante de pulmão. As culturas de ambos os grupos também foram colocadas em hipóxia e analisada a expressão indireta de óxido nítrico (NO) por meio da medida de nitrato. Resultado: as células do grupo HPTEC com morfologia endotelial foram marcadas positivamente com CD31 e apresentaram características semelhantes às do grupo CE. Em relação ao stress mecânico, na condição estática as células HPTEC expressaram menor quantidade de óxido nítrico sintase endotelial (eNOS). Quando submetidas a stress de alta intensidade (shear stress >= 15 dynes/cm2), as reduções ficaram ainda mais evidentes, sinalizando uma disfunção endotelial. Na análise de outras proteínas, como GRP94, GRP78, HSP70, as respostas também foram menores no alto fluxo. Na avaliação imunohistoquímica da camada íntima do vaso pulmonar, a HSP70 apresentava-se diminuída, corroborando os achados das culturas. Os valores de NO foram inferiores no grupo HPTEC quando se comparam hipóxia e normóxia. Conclusão: (A) A avaliação morfológica mostrou que as culturas de células HPTEC eram endoteliais. (B) A análise funcional revelou que estas células apresentaram redução de resposta, o que caracteriza alteração da proteostase, que se tornou mais evidente quando foram submetidas a shear stress de alta magnitude. A hipóxia reduziu a produção de NO, entretanto sem diferenciar os grupos celulares estudados / Introduction: Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is included in group 4 of the International Classification of Pulmonary Hypertension (PH). It is characterized by persistent obstruction by blood clots in the pulmonary circulation, associated with the presence of PH, after 3 months of effective anticoagulation. The treatment of choice is pulmonary endarterectomy (PEA). However, some of the pathophysiological mechanisms involved in this form of hypertension still remain uncertain. The redirection of pulmonary blood flow and hypoxia play an important role in CTEPH, and also, in cases of residual pulmonary hypertension after PEA surgery. Nevertheless, there is insufficient data from the pulmonary endothelial cell responses to this flow and oxygenation changes, reflecting the need to further study of cellular proteostasis in this disease. Objective: (A) Morphological characterization of cells in cultures from the pulmonary artery of CTEPH patients submitted to PEA. (B) Evaluation of the response of endothelial cells, through the analysis of proteins involved in cellular proteostasis, when submitted to different levels of mechanical stress and hypoxia. Method: Thrombus extracted by PEA were processed and the cells removed were cultured, marked with CD31 and submitted to mechanical stress for 24 hours and constituted the group CTEPH. Cellular proteostasis was measured by the quantification of the proteins expressed in cultures and in pulmonary vascular tissue by immunohistochemistry analysis. As a control group, the human pulmonary endothelial cells (EC) and pulmonary artery tissue from lung transplant donors were used. Cultures of both groups were also placed in hypoxia and the indirect expression of nitric oxide (NO) was analyzed by nitrate measurement. Results: The cells with endothelial morphology from the CTEPH group were positively marked with CD31 and presented similar characteristics as the EC group. Regarding mechanical stress, in the static condition, the CTEPH cells expressed a lesser amount of endothelial nitric oxide synthase (eNOS). When submitted to high flow (shear stress > 15 dynes / cm2) the reductions became even more evident, signaling an endothelial dysfunction. In the analysis of other proteins, such as GRP94, GRP78, HSP70, responses were also lower in high shear stress. In the immunohistochemistry analysis of the intimal layer of the pulmonary vessel HSP70 was diminished, corroborating with the findings of the cultures. The NO values were lower in the CTEPH group when compared hypoxia and normoxia. Conclusion: (A) Morphological evaluation showed that cultures of CTEPH cells were endothelial. (B) Functional analysis revealed that these cells had reduced response, which characterizes proteostasis alterations, which became more evident when they underwent shear stress of high magnitude. Hypoxia reduced NO production, however without differentiating the cell groups studied

Os objetivos do estudo foram avaliar as características clínicas das embolias arteriais sistêmicas no curso da endocardite infecciosa, a distribuição temporal, os fatores de risco de embolia e a influência prognóstica da embolia no curso da doença. Foram estudados 629 episódios de endocardite infecciosa. A idade dos pacientes variou de 2 meses a 83 anos (média 37,9 anos; desvio padrão 17,3). Ocorreram 396 (63%) episódios em homens e 233 (47%) em mulheres. Em 538 (85%) episódios, os pacientes eram portadores de doença cardíaca prévia, 272 (43%) com valvopatia, 224 (36%) portadores de prótese valvar cardíaca, 29 (5%) com doença cardíaca congênita, 13 (2%) com outras cardiopatias e 91 (14%) pacientes não apresentavam evidência de cardiopatia prévia. Os agentes etiológicos foram os estreptococos em 297 (47%) pacientes, os enterococos em 51 (8%), os Staphylococcus aureus em 77 (12,6%), os Staphylococcus epidermidis em 56 (9%), as bactérias gram-negativas em 33 (5%), os fungos em nove (1,4%), e outros microorganismos em 27 (4%). Em 79 (13%) pacientes as hemoculturas foram negativas. Os pacientes receberam tratamento clínico em 376 (60%) episódios e cirúrgico em 253 (40%). Para a análise estatística foram utilizados além da estatística descritiva, o método de Kaplan-Meier para avaliar a sobrevida livre de embolia e o prognóstico, comparadas com os testes de Log-rank e Breslow. Em seguida para a estimativa de riscos, foi ajustado o modelo de riscos proporcionais de Cox. As embolias arteriais ocorreram em 133 (21%) pacientes, cerebrais em 63 (47%), extracerebrais em 57 (43%) e cerebrais a extracerebrais em 13 (10%) pacientes. A distribuição temporal das embolias foi decrescente após o início dos sintomas. O risco de embolia não revelou diferença significativa quanto a idade, a sexo, o estado cardíaco, presença e número de vegetações identificadas no ecocardiograma e a modalidade de tratamento clínico ou cirúrgico. Os pacientes com endocardite causada por Staphylococcus aureus apresentaram risco de ocorrência de embolia 2,9 vezes maior do que os pacientes com endocardite causada por outros agentes etiológicos. Nos pacientes com endocardite infecciosa em prótese mitral e aórtica com vegetação identificada no ecocardiograma, o risco de embolia foi respectivamente 2,4 e 3,3 vezes maior relação aos pacientes com endocardite em valva natural ou em prótese sem vegetação. O risco de embolia foi menor a medida que o tempo decorrido entre o início dos sintomas e o tratamento aumentou. O risco de óbito nos pacientes que sofreram embolia duplicou em relação aos pacientes que não sofreram embolia. / The objectives of the study were to evaluate the clinical characteristics of systemic arterial embolism at infective endocarditis courses, the time related distribution of emboli, risk predictors and prognostic influence of emboli during active disease. So far, we studied 629 episodes of left-sided endocarditis. The patients were aged 37.9 ± 17.3 years; 396 (63%) episodes occurred in men; 233 (47%) in women; 538 (85%) episodes occurred in patients with heart disease: 272 (43%) had valvular heart disease, 224 (36%) had prosthetic heart valves, 29 (5%) had congenital heart disease, 13 (2%) had others cardiac diseases and 91 (14%) had no known heart disease. The causative microorganisms were streptococci in 297 (47%) patients, enterococci in 51 (8%), Staphylococcus aureus in 77 (1 2.6%), Sfaphylococcus epidermidis in 56 (9%), gram-negative bacteria in 33 (5%), fungi in nine (1.4%), and other microorganisms in 27 (4%); 79 (13%) patients had negative blood cultures. The treatment was medical in 376 (60%) and surgical in 253 (40%) episodes. Statistical analysis was pet-formed with descriptive analysis, with Kaplan-Meier methods to evaluate survival free of emboli and prognosis, and Cox proportional hazards model for risk analysis; 133 (21%) patients had an embolic event; 63 (47%) were cerebral emboli and 57 (43%) were extracerebral emboli and 13 (10%) were cerebral and extracerebral. The time-related distribution showed decrease in the incidence after beginning of symptoms. The risk for emboli was not significantly different relative to age, sex, cardiac status, presence or number of vegetations at echocardiogram, and medical or surgical treatment. The risk of emboli was 2.97 times higher in patients with Staphylacoccus aureus endocarditis. The risk of embolism in patients with infective endocarditis in mitral and aortic prosthetic valve with vegetations were 2.4 and 3.3 times higher. The risk of embolism decrease as the time elapsed between beginning of symptoms and treatment increased, suggesting a lower risk in less acute disease. Risk of death was 2.01 times higher in patients with embolism.

Introdução: O termo tromboembolismo venoso (TEV) engloba trombose venosa profunda (TVP) e/ou tromboembolismo pulmonar (TEP). TEV tem sido considerado incomum após cirurgia de revascularização miocárdica (CRM), e Diretrizes recomendam profilaxia mecânica para todos os pacientes e acrescentar profilaxia com heparina apenas se o tempo de internação hospitalar for prolongado por complicações não hemorrágicas (Grau 2C). Objetivo: Pesquisar o diagnóstico de TEV no pós-operatório de CRM, independente de suspeita clínica, e analisar se os resultados podem contribuir para melhor definição das características clínicas de TEV após CRM. Métodos: Em estudo observacional, prospectivo, unicêntrico, 100 pacientes com doença arterial coronariana crônica realizaram tomografia computadorizada da artéria pulmonar (multidetectores-64) e ultrassonografia compressiva dos membros inferiores após CRM eletiva. Pacientes com alto risco para TEV foram excluídos. Resultados: Por livre escolha dos cirurgiões, 83 cirurgias foram realizadas com circulação extracorpórea e 17 sem extracorpórea. Em média, tomografia e ultrassonografia foram realizadas 7 ± 3 dias após a cirurgia. TEP isolada foi observada em 13/100 (13%), TEP e TVP simultâneos em 8/100 (8%), e TVP isolada em 4/100 (4%) pacientes, totalizando 25/100 (25%) TEVs. Entre as 21 TEPs, 3/21 (14%) envolveram artérias subsegmentares, 15/21 (71%) artérias segmentares, 1/21 (5%) artéria lobar e 2/21 (10%) artérias pulmonares centrais (tronco da artéria pulmonar e/ou seus ramos principais). Das 12 TVPs, todas foram distais (abaixo da veia poplítea) e 2/12 (17%) foram também proximais; 5/12 (42%) foram unilaterais, das quais 3/5 (60%) acometeram a perna contralateral à safenectomia. Nenhum TEV causou instabilidade hemodinâmica e nenhum deles foi clinicamente suspeitado. Conclusões: TEV é frequente e subdiagnosticado após CRM, talvez porque a maioria tenha localização distal e porque os procedimentos habituais desta cirurgia dificultam a suspeita diagnóstica. Os resultados enfatizam a recomendação de recentes Diretrizes que sugerem profilaxia mecânica para todos os pacientes, e ressaltam a necessidade de estudos randomizados para avaliar a relação de benefícios e os riscos de profilaxia farmacológica / Background: Venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and/or pulmonary embolism (PE). Currently, VTE has been considered uncommon after coronary artery bypass grafting (CABG) and Guidelines suggest mechanical prophylaxis and adding prophylactic heparin if hospital course is prolonged by nonhemorrhagic complications (Grade2C). Objective: To search VTE after CABG, independent of clinical suspicion, and to analyze whether the results can aid in better defining the clinical characteristics of VTE after CABG. Methods: In a prospective, observational, single-center study, 100 patients with coronary artery disease underwent computed tomographic pulmonary angiography (multidetector-64) and lower-extremity venous compressive ultrasound after elective CABG. Patients at high risk for VTE were excluded. Results: At the discretion of surgeons, 83 surgeries were on-pump and 17 off-pump. On average, tomography and ultrasound were performed 7 ± 3 days after CABG. Isolated PE was observed in 13/100 (13%) patients, simultaneous PE and DVT in 8/100 (8%), and isolated DVT in 4/100 (4%), totaling 25/100 (25%) VTEs. Of the PEs 3/21 (14%) involved subsegmental, 15/21 (71%) segmental, 1/21 (5%) lobar and 2/21 (10%) central pulmonary arteries. Of the 12 DVTs all were distal (below the popliteal vein) and 2/12 (17%) were also proximal; 5/12 (42%) were unilateral, of which 3/5 (60%) on the contralateral vein saphenous harvested leg. No VTE caused hemodynamic instability and none was clinically suspected. Conclusions: VTE is frequent and underdiagnosed perhaps because the majority is distally localized and because the ordinary procedures of GABG conceal the diagnostic suspicion. The results emphasize the current guidelines\' recommendation suggesting mechanical prophylaxis for all patients and highlight the necessity of randomized studies to assess the risk/benefit ratio of pharmacological prophylaxis